Cerebrospinal fluid cytokine levels and dexamethasone therapy in bacterial meningitis
Authors:
- Kenji OkadaKOKenji Okada
- Kohji UedaKUKohji Ueda
- Hidetoshi TakadaHTHidetoshi Takada
- Mitsuhiro OhtaMOMitsuhiro Ohta
- Tomonobu AokiTATomonobu Aoki
- Naoko KinukawaNKNaoko Kinukawa
- Sumio MiyazakiSMSumio Miyazaki
- Toshiro HaraTHToshiro Hara
- 1 July 1999
- journal article
- Published by Elsevier in Journal of Infection
- Vol. 39 (1) , 55-60
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Treatment of Bacterial MeningitisNew England Journal of Medicine, 1997
- Toxicity of TNFα and platelet activating factor for human NT2N neurons: A tissue culture model for human immunodeficiency virus dementiaJournal of NeuroVirology, 1996
- Beneficial effects of dexamethasone in children with pneumococcal meningitisThe Pediatric Infectious Disease Journal, 1995
- Bacterial meningitis: Mechanisms of disease and therapyEuropean Journal of Pediatrics, 1995
- Dexamethasone therapy for bacterial meningitis in childrenThe Lancet, 1993
- Should we use dexamethasone in meningitis? The Meningitis Working Party of the British Paediatric Immunology and Infectious Diseases Group.Archives of Disease in Childhood, 1992
- Aseptic meningitis in children: Correlation between fever and interferon-gamma levelEuropean Journal of Pediatrics, 1991
- Dexamethasone treatment for bacterial meningitis in children and adultsThe Pediatric Infectious Disease Journal, 1989
- Correlation of interleukin-1β and cachectin concentrations in cerebrospinal fluid and outcome from bacterial meningitisThe Journal of Pediatrics, 1989
- Dexamethasone Therapy for Bacterial MeningitisNew England Journal of Medicine, 1988